MUTANTE INTERLEUKIN-2-POLYPEPTIDE

European patent · EP2673294 · In force

Register entry

Publication number
EP2673294
Application number
EP12702045
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Feb 7, 2012
Published
Dec 18, 2013
Granted
Apr 27, 2016
Protection ends at the latest
Feb 6, 2032
Next annual fee due
Feb 28, 2027
IPC classes
C07K 14/55 (2006.01)
C12N 15/26 (2006.01)
A61K 39/395 (2006.01)
A61K 47/48 (2006.01)
Priority
EP 11153964 10.02.2011
EP 11164237 29.04.2011
PCT application
PCT/EP2012/051991 07.02.2012
PCT publication
WO2012/107417 16.08.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 1, 2026

    Change

    Published in Swissreg on 01.03.2026

  2. Mar 1, 2025

    Change

    Published in Swissreg on 01.03.2025

  3. Mar 1, 2024

    Change

    Published in Swissreg on 01.03.2024

  4. Mar 6, 2023

    Change

    Published in Swissreg on 06.03.2023

  5. Oct 19, 2021

    Address changed

    Owner
    Roche Glycart AG, Wagistrasse 18, 8952 Schlieren → Roche Glycart AG, Wagistrasse 10, 8952 Schlieren

    Published in Swissreg on 19.10.2021

  6. Apr 27, 2016

    Granted

    Published in Swissreg on 27.04.2016

Parties

Holder

Roche Glycart AG

Wagistrasse 10, 8952 Schlieren

Inventor

AST, Oliver

CH-8303 Bassersdorf

BRUENKER, Peter

CH-8335 Hittnau

FREIMOSER-GRUNDSCHOBER, Anne

CH-8050 Zuerich

HERTER, Sylvia

CH-8105 Regensdorf

HOFER, Thomas U.

CH-8052 Zuerich

HOSSE, Ralf

CH-6330 Cham

KLEIN, Christian

CH-8906 Bonstetten

MOESSNER, Ekkehard

CH-8280 Kreuzlingen

NICOLINI, Valeria G.

CH-8703 Erlenbach/ZH

UMANA, Pablo

CH-8832 Wollerau

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.